# Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)

> **NCT02958163** · PHASE2 · TERMINATED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 3 (actual)

## Conditions studied

- Liver Neoplasms
- Hepatocellular Cancer

## Interventions

- **PROCEDURE:** Trans-arterial Chemo-Embolization
- **DRUG:** Doxorubicin
- **RADIATION:** Stereotactic Ablative Radiotherapy

## Key facts

- **NCT ID:** NCT02958163
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-20
- **Primary completion:** 2017-10-17
- **Final completion:** 2017-10-17
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2017-11-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02958163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02958163, "Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02958163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*